Related Experiment Video
Updated: Jan 11, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
From the Skin to Small Bowel: Metastatic Melanoma as a Hidden Source of Gastrointestinal Bleeding
Leonid Drober1, Yosor Fiesal1, Sa'd Sayida1
1General Surgery, Rambam Medical Center, Haifa, ISR.
Abstract:
Malignant melanoma involving the small bowel, whether primary or metastatic, is rare and often remains undiagnosed during life due to its asymptomatic course or nonspecific clinical presentation. Here, we report the case of an 81-year-old man with a history of spindle cell melanoma of the scalp, treated five years earlier, who presented to the emergency department with loss of consciousness. Laboratory tests revealed severe anemia (hemoglobin: 4.2 g/dL), and rectal examination demonstrated melena. Upper and lower endoscopy failed to identify a bleeding source. Abdominal CT showed a circular filling defect in the proximal jejunum. Subsequent enteroscopy revealed an ulcerated, friable mass occupying more than 50% of the luminal circumference. The patient underwent laparoscopic segmental resection of a 10 cm jejunal segment containing the lesion, followed by primary anastomosis. Histopathological analysis confirmed metastatic malignant melanoma infiltrating the intestinal wall. Small bowel melanoma is a rare but important cause of gastrointestinal bleeding. In patients with a history of melanoma presenting with unexplained anemia or overt bleeding, small bowel metastasis should be considered. Surgical resection offers both diagnostic confirmation and effective treatment.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

